Advos

Optimi Health Corp. is featured in a Diamond Equity Research initiation report that underscores its position as a commercial-stage psychedelic manufacturer with GMP infrastructure and growing traction in Australia.

The rise of AI tools like ChatGPT is changing how travelers search for hotels, prompting the industry to optimize its digital footprint to appear in AI-generated recommendations.

A new doctoral study from Karolinska Institutet finds that sexual difficulties are common among young cancer survivors, varying by cancer type and treatment intensity.

Recent central bank gold liquidations to support currencies and energy purchases amid Middle East turmoil could set the stage for a major gold rally, benefiting mining companies like Numa Numa Resources Inc.

Major companies like Microsoft and Uber are cutting back on AI coding tools due to unexpected high costs, highlighting a broader challenge for enterprises adopting AI.

Redwood AI Corp. announced DTC eligibility for its common shares and a $114,000 engagement with InvestorBrandNetwork for market awareness services through 2026.

Regentis Biomaterials' GelrinC, a potential first-in-class off-the-shelf solution for knee cartilage repair, shows superior pain improvement and faster recovery in clinical trials, targeting a $3 billion U.S. market with no comparable competitor.

Nevada Organic Phosphate Inc. has waived the forced warrant acceleration for over 23.6 million warrants from its 2025 private placement, allowing holders to keep original terms, while continuing its 2026 exploration program with temporary pauses for crew rest and ongoing field work.

VolitionRx provided a corporate update highlighting clinical and commercial advancements, including a feline lymphoma manuscript submission tied to a potential $5 million milestone and licensing discussions with over a dozen global diagnostic companies.

Cardio Diagnostics Holdings (NASDAQ: CDIO) is presenting its AI-driven cardiovascular risk assessment tools at four national benefits conferences this June, targeting employers and plan administrators to address cardiovascular disease as a major driver of healthcare costs and productivity losses.

Tonix Pharmaceuticals announced publication of positive Phase 1 data for its anti-CD40L monoclonal antibody TNX-1500, showing favorable safety and tolerability in healthy volunteers, supporting a planned Phase 2 kidney transplant rejection study in 2026.

Silvercorp Metals Inc. announced record fiscal 2026 revenue of $438.1 million, driven by higher silver prices, and highlighted strong operating cash flow and growth initiatives.

TransCode Therapeutics has launched a Phase 2a clinical trial of its lead candidate TTX-MC138 in colorectal cancer patients with minimal residual disease, aiming to reduce recurrence risk in a high-risk population.

SOLOWIN HOLDINGS signed a non-binding MOU with Bahrain's national payments hub BENEFIT to explore integrating stablecoin technology into the kingdom's payments ecosystem, potentially advancing regulated digital asset infrastructure.

Search Minerals Inc. has initiated its 2026 critical rare earth element exploration program in southeastern Labrador, targeting resource expansion and bulk sample collection to advance its patented extraction process toward production.

GeoVax Labs CEO David Dodd will present on building a resilient infectious disease strategy using MVA-based vaccine technologies in a May 28 webinar, highlighting the need to move beyond single-threat approaches amid recent outbreaks.

tZERO Group's subsidiary VerifyInvestor.com has integrated its accredited investor verification services into the PandoAlts Market Checks platform, aiming to streamline onboarding and compliance for private market and alternative investments.

GrocerIQ Holdings announces the initial rollout of AI-driven neighborhood grocery stores across Los Angeles, aiming to improve local access to essentials through smaller-format retail environments powered by proprietary physical AI technology.

Affluence Corporation announced a letter of intent to acquire Triar Commerce LLC, potentially boosting pro forma annualized revenue to $220 million, but the deal faces financing and due diligence hurdles.